According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for<unk><unk> <unk>  lymphoma.
Splenic marginal zone lymphoma screening
Langerhans cell histiocytosis screening
Mast cell leukemia screening
Enteropathy-associated T-cell lymphoma screening
Myelodysplastic syndrome screening
Autoimmune polyendocrine syndrome screening
Lymphomatoid granulomatosis screening
Acute lymphoblastic leukemia screening